Literature DB >> 27175268

The polycythemia vera stem cell.

J L Spivak1.   

Abstract

Entities:  

Keywords:  ALDH activity in stem cells; JAK2 V617F mutation; PV initiating stem cell

Year:  2014        PMID： 27175268      PMCID： PMC4851290          DOI： 10.1038/leusup.2014.13

Source DB:  PubMed          Journal:  Leuk Suppl        ISSN： 2044-5210


× No keyword cloud information.
  7 in total

1.  Polycythemia vera is not initiated by JAK2V617F mutation.

Authors:  Roberto H Nussenzveig; Sabina I Swierczek; Jaroslav Jelinek; Amos Gaikwad; Enli Liu; Srdan Verstovsek; Jaroslav F Prchal; Josef T Prchal
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

2.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

Authors:  Chloé James; Valérie Ugo; Jean-Pierre Le Couédic; Judith Staerk; François Delhommeau; Catherine Lacout; Loïc Garçon; Hana Raslova; Roland Berger; Annelise Bennaceur-Griscelli; Jean Luc Villeval; Stefan N Constantinescu; Nicole Casadevall; William Vainchenker
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

3.  Disease burden at the progenitor level is a feature of primary myelofibrosis: a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients.

Authors:  Brady L Stein; Donna M Williams; Ophelia Rogers; Mary Ann Isaacs; Jerry L Spivak; Alison R Moliterno
Journal:  Exp Hematol       Date:  2010-10-01       Impact factor: 3.084

4.  Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders.

Authors:  Brady L Stein; Donna M Williams; Nae-Yuh Wang; Ophelia Rogers; Mary Ann Isaacs; Naveen Pemmaraju; Jerry L Spivak; Alison R Moliterno
Journal:  Haematologica       Date:  2010-02-04       Impact factor: 9.941

5.  Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Authors:  Alexandre Theocharides; Marjorie Boissinot; François Girodon; Richard Garand; Soon-Siong Teo; Eric Lippert; Pascaline Talmant; Andre Tichelli; Sylvie Hermouet; Radek C Skoda
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

6.  Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.

Authors:  Alison R Moliterno; Donna M Williams; Ophelia Rogers; Mary Ann Isaacs; Jerry L Spivak
Journal:  Exp Hematol       Date:  2008-08-23       Impact factor: 3.084

7.  Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells.

Authors:  Ann Mullally; Steven W Lane; Brian Ball; Christine Megerdichian; Rachel Okabe; Fatima Al-Shahrour; Mahnaz Paktinat; J Erika Haydu; Elizabeth Housman; Allegra M Lord; Gerlinde Wernig; Michael G Kharas; Thomas Mercher; Jeffery L Kutok; D Gary Gilliland; Benjamin L Ebert
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.